BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30

• Biotech Bay

  ESI BIO - A Division Of BioTime Launches New Research Technology Platform, Vascunet Pericyte Co-Culture Assay

  September 2, 2015

   · 

  5 min read
• Business

  Titan Spine Enters Distribution Agreement With MBA To Expand Endoskeleton Titanium Implant Portfolio Offering In Europe

  September 2, 2015

   · 

  1 min read
• BioMidwest

  Leadership With A Legacy: Medtronic’s Gordon Steere To Be Honored With Arizona BioIndustry Association’s Pioneer Award For Lifetime Achievement

  September 2, 2015

   · 

  3 min read
• Pharm Country

  Teleflex Incorporated Release: Weck Efx Shield Fascial Closure System Selected As A 2015 Innovation Of The Year By Society Of Laparoendoscopic Surgeons

  September 2, 2015

   · 

  1 min read
• Biotech Bay

  Hitachi Chemical Diagnostics, Inc. Release: New Products For Exosome Isolation To mRNA Purification

  September 2, 2015

   · 

  1 min read
• Policy

  Bristol-Myers Squibb Release: FDA Accepts Supplemental Biologics License Application for Opdivo (nivolumab) in Previously Treated Non-Squamous Non-Small Cell Lung Cancer Patients

  September 2, 2015

   · 

  12 min read
• The Medicines Company Release: MATRIX Trial Results Presented At Hot Line Session Of ESC Congress 2015 And Simultaneously Published In The New England Journal of Medicine

  September 2, 2015

   · 

  6 min read
• Letter To Orexo AB Shareholders From CEO Nikolaj Sørensen

  September 2, 2015

   · 

  1 min read
• BioMidwest

  Navidea Announces Dual Listing On Tel Aviv Stock Exchange

  September 2, 2015

   · 

  1 min read
• Drug Development

  Janssen Biotech Inc. Release: U.S. FDA Approves Update Of SIMPONI ARIA (golimumab for infusion) Label To Include Improvement In Both Physical And Emotional Measures Of Health When Treating Moderately To Severely Active Rheumatoid Arthritis

  September 2, 2015

   · 

  12 min read